跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 106,366 条关于
“MTAP-deleted cancer”
全部
106,366
临床试验
87,961
药物
2,386
机构
1,104
资讯
14,915
去年
IDEAYA Biosciences Submits IND for IDE892 PRMT5 Inhibitor Targeting MTAP-Deleted Lung Cancer
去年
Tango Therapeutics' TNG462 Receives Orphan Drug Status for Pancreatic Cancer as Company Advances PRMT5 Inhibitor Programs
去年
Ryvu Therapeutics Advances Synthetic Lethality Pipeline with Promising Preclinical Data at AACR 2025
3年前
Tango Therapeutics Initiates Phase 1/2 Trial of TNG462 for MTAP-Deleted Solid Tumors
去年
Novel Synthetic Lethal Approaches Show Promise in Targeting MTAP and SMARCA4 Mutations in Lung Cancer
去年
Bayer Secures Global License for Novel PRMT5 Inhibitor Targeting MTAP-Deleted Tumors
8个月前
Tango Therapeutics Names New CEO as Vopimetostat Advances to Pivotal Studies
去年
APAC Biopharma Trends: ADCs, CGTs, AI, and Clinical Trial Dominance in 2025
去年
IDEAYA Biosciences Presents Promising Phase 1 Results for IDE397 in MTAP-Deleted Cancers
2年前
Ryvu Therapeutics to Present Promising RVU120 and Synthetic Lethality Data at Major Oncology Conferences
第 1 页,共 1492 页
上一页
下一页